What valuation metrics does the news use to conclude Stepan (SCL) is undervalued?

The news states that Stepan (SCL) is trading below its estimated fair value based on two valuation methods: a Price-to-Sales (P/S) ratio analysis — where the stock's current P/S is 0.6x, matching the 'fair' P/S of 0.6x but sitting below higher industry averages — and a Discounted Cash Flow (DCF) model, which also indicates the stock is undervalued.

What key corporate actions did Stepan (SCL) take alongside its Q2 earnings report?

Alongside reporting strong Q2 results, Stepan (SCL) affirmed its dividend and announced governance changes — actions that contributed to significant share price momentum, despite the company's recent gains and a prior period of unprofitability.

Stepan (SCL) Reports Strong Q2 Results, Affirms Dividend Amid Valuation Analysis

Aug 7, 2026

Stepan Company reported strong Q2 results and affirmed its dividend, citing governance changes. While valuation models suggest the stock is undervalued, risks from net losses remain.

Yahoo Finance UK

2026-02-23

US Stepan to close New Jersey surfactants site; decommission other assets by mid-2026

2026-02-24

Stepan to shutter assets under $100M savings plan

2026-03-03

Stepan Company Launches Cost-Cutting Plan

2026-04-02

Stepan Stock Crosses 200-Day Moving Average Despite Earnings Miss

2026-04-03

Stepan Company Stock: Steady in Volatile Materials Sector—What You Need to Watch